Evidence map›Paper›PMID 39611178›Full record

ArticleFrontiers in pharmacology2024

Effectiveness analysis of a pharmacist-led intervention for orthopedic perioperative use of antibiotics: a retrospective cohort study.

Danwei Wu, Yingxu Li, Jiancun Zhen, Yong Wu, Shuang Ren, Yuan Zhao, Ning Sun, Xuanzi Lin, Liangpeng Lai, Wei Zhang

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Danwei Wu *Department of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Yingxu Li *Department of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Jiancun ZhenDepartment of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Yong WuDepartment of Foot and Ankle Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Shuang RenDepartment of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Yuan ZhaoDepartment of Foot and Ankle Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Ning SunDepartment of Foot and Ankle Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Xuanzi LinDepartment of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Liangpeng LaiDepartment of Foot and Ankle Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Wei ZhangDepartment of Pharmacy, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Following the Chinese guidelines' recommendation to completely cancel routine cephalosporin skin tests, the choice of cephalosporin as surgical prophylactic medication was affected. This was due to the limited cognition of the predictive value of cephalosporin skin test or the desire to avoid medical disputes. The aim of this retrospective study was to evaluate whether the pharmacist-led perioperative antibiotic prophylaxis model could improve clinicians' medical behavior in choosing cephalosporin antibiotics for surgical prophylaxis. Methods: From July 2021 to May 2022, a retrospective analysis was conducted on the selection of surgical preventive medication, skin test, postoperative infection and adverse drug reactions in foot and ankle surgery. The study was divided into three period: the rountine cephalosporin skin test period (Period I: Skin Test), the period when the routine cephalosporin skin test was cancelled but the pharmacist did not intervene (Period II: Cancel Skin Test), and the period when the pharmacist-led perioperative antibiotic prophylaxis was implemented after the cancellation of the cephalosporin skin test (Period III: Pharmacist Intervention). Results: A total of 1,583 patients were enrolled in this study. There was no significant difference in the utilization rate of cefuroxime between the routine skin test stage and the skin test cancelled stage [74.92% (Period I) vs. 74.54% (Period II), Conclusion: The pharmacist-led perioperative antibiotic prophylaxis model can significantly improve the medical behavior of clinicians in choosing cephalosporin antibiotics as surgical prophylactic medication and optimize the perioperative medication plan.

Indexed as

antimicrobial stewardshiporthopedic surgerypharmacist interventionsurgical prophylaxisβ-lactam allergy

Identifiers

PMID39611178
PMCPMC11604034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.